Table 3.
Background characteristics of subjects in the cross-sectional study.
| Characteristics | Number |
|---|---|
| All | 105 |
| Age (years) * | 69.0 (21–86) |
| Male (%) ** | 73 (69.5) |
| Diabetes (%) ** | 10 (9.5) |
| PC | 41 |
| Resectable | 17 |
| Stage IA | 2 |
| Stage IB | 0 |
| Stage IIA | 11 |
| Stage IIB | 4 |
| Unresectable | 24 |
| Stage III | 11 |
| Stage IV | 13 |
| High-risk diseases (HR) | 37 |
| PCL | 24 |
| IPMN | 21 |
| CP | 13 |
| Others | 27 |
| AIP | 13 |
| NET | 6 |
| SPN | 1 |
| Undefined pancreatic mass | 1 |
| Normal | 6 |
PC was staged according to the UICC classification, 7th edition. * Data are shown as median and range values. ** Data are shown as absolute values and percentages. PC, pancreatic cancer; PCL, pancreatic cystic lesions; IPMN, intraductal papillary mucinous neoplasm; CP, chronic pancreatitis; AIP, autoimmune pancreatitis; NET, pancreatic neuroendocrine tumors; SPN, solid pseudo-papillary neoplasms.